Dynamic measurement of extracellular opioid activity: Status quo, challenges, and significance in rewarded behaviors

ACS Chemical Neuroscience

Volumn 6, Issue 1, 2015, Pages 94-107

  Murphy, Niall P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

addiction; Extracellular; microdialysis; neuropeptide; opiate; opioid; reward

Indexed keywords

EXTRACELLULAR OPIOID; OPIATE; OPIATE PEPTIDE; UNCLASSIFIED DRUG;

ACT; BEHAVIOR; BIOTRANSFORMATION; CALCIUM CELL LEVEL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; DENDRITE; DOWN REGULATION; DRUG DEPENDENCE; EXTRACELLULAR SPACE; GASTROINTESTINAL TRANSIT; HUMAN; LATERAL HYPOTHALAMUS; NEUROBIOLOGY; NUCLEUS ACCUMBENS; PHYSIOLOGY; PLEASURE; PRIORITY JOURNAL; REVIEW; REWARD; SECOND MESSENGER; SIGNAL TRANSDUCTION; ANIMAL; EXTRACELLULAR FLUID; METABOLISM; MICRODIALYSIS; NONLINEAR SYSTEM;

ANIMALS; EXTRACELLULAR FLUID; HUMANS; MICRODIALYSIS; NONLINEAR DYNAMICS; OPIOID PEPTIDES; REWARD;

EID: 84921525498     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500295q     Document Type: Review

References (118)

1. Fricker, L. D. (2012) Neuropeptides and Other Bioactive Peptides: From Discovery to Function Colloq. Ser. Neuropept. 1, 1-122
2. Klavdieva, M. M. (1995) The History of Neuropeptides I Front. Neuroendocrinol. 16, 293-321
3. Bodnar, R. J. (2014) Endogenous opiates and behavior: 2013 Peptides 62C, 67-136
4. Borbely, E.; Scheich, B.; and Helyes, Z. (2013) Neuropeptides in learning and memory Neuropeptides 47, 439-450
5. Witkin, J. M.; Statnick, M. A.; Rorick-Kehn, L. M.; Pintar, J. E.; Ansonoff, M.; Chen, Y.; Tucker, R. C.; and Ciccocioppo, R. (2014) The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence Pharmacol. Ther. 141, 283-299
6. Milligan, G. (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective Mol. Pharmacol. 64, 1271-1276
7. Zamir, N.; Palkovits, M.; Weber, E.; Mezey, E.; and Brownstein, M. J. (1984) A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra Nature 307, 643-645
8. Raynor, K.; Kong, H.; Chen, Y.; Yasuda, K.; Yu, L.; Bell, G. I.; and Reisine, T. (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors Mol. Pharmacol. 45, 330-334
9. Pasternak, G. W. and Pan, Y. X. (2013) Mu opioids and their receptors: Evolution of a concept Pharmacol. Rev. 65, 1257-1317
10. Pasternak, G. W. (2014) Opioids and their receptors: Are we there yet? Neuropharmacology 76 (Pt B) 198-203
11. Niikura, K.; Narita, M.; Narita, M.; Nakamura, A.; Okutsu, D.; Ozeki, A.; Kurahashi, K.; Kobayashi, Y.; Suzuki, M.; and Suzuki, T. (2008) Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state Neurosci. Lett. 435, 257-262
12. Narita, M.; Kishimoto, Y.; Ise, Y.; Yajima, Y.; Misawa, K.; and Suzuki, T. (2005) Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state Neuropsychopharmacology 30, 111-118
13. Manzanares, J.; Wagner, E. J.; Lookingland, K. J.; and Moore, K. E. (1992) Effects of immunoneutralization of dynorphin1-17 and dynorphin1-8 on the activity of central dopaminergic neurons in the male rat Brain Res. 587, 301-305
14. Burbach, J. P. (2011) What are neuropeptides? Methods Mol. Biol. 789, 1-36
15. van den Pol, A. N. (2012) Neuropeptide transmission in brain circuits Neuron 76, 98-115
16. Fuxe, K.; Borroto-Escuela, D. O.; Romero-Fernandez, W.; Zhang, W. B.; and Agnati, L. F. (2013) Volume transmission and its different forms in the central nervous system Chin. J. Integr. Med. 19, 323-329
17. Drake, C. and Chavkin, C. (2005) Dendritic Dynorphin Release in the Hippocampal Formation, in Dendritic Neurotransmitter Release (Ludwig, M.; Ed.), pp 257-268, Springer: New York.
18. Bjelke, B. and Fuxe, K. (1993) Intraventricular beta-endorphin accumulates in DARPP-32 immunoreactive tanycytes Neuroreport 5, 265-268
19. Hoistad, M.; Samskog, J.; Jacobsen, K. X.; Olsson, A.; Hansson, H. A.; Brodin, E.; and Fuxe, K. (2005) Detection of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain Brain Res. 1041, 167-180
20. MacMillan, S. J.; Mark, M. A.; and Duggan, A. W. (1998) The release of beta-endorphin and the neuropeptide-receptor mismatch in the brain Brain Res. 794, 127-136
21. Leng, G. and Ludwig, M. (2008) Neurotransmitters and peptides: Whispered secrets and public announcements J. Physiol. 586, 5625-5632
22. Ludwig, M. and Pittman, Q. J. (2003) Talking back: Dendritic neurotransmitter release Trends Neurosci. 26, 255-261
23. Henry, J. N. and Manaker, S. (1998) Colocalization of substance P or enkephalin in serotonergic neuronal afferents to the hypoglossal nucleus in the rat J. Comp. Neurol. 391, 491-505
24. Chou, T. C.; Lee, C. E.; Lu, J.; Elmquist, J. K.; Hara, J.; Willie, J. T.; Beuckmann, C. T.; Chemelli, R. M.; Sakurai, T.; Yanagisawa, M.; Saper, C. B.; and Scammell, T. E. (2001) Orexin (hypocretin) neurons contain dynorphin J. Neurosci. 21, RC168
25. Hentges, S. T.; Nishiyama, M.; Overstreet, L. S.; Stenzel-Poore, M.; Williams, J. T.; and Low, M. J. (2004) GABA release from proopiomelanocortin neurons J. Neurosci. 24, 1578-1583
26. Kits, K. S.; Dreijer, A. M.; Lodder, J. C.; Borgdorff, A.; and Wadman, W. J. (1997) High intracellular calcium levels during and after electrical discharges in molluscan peptidergic neurons Neuroscience 79, 275-284
27. Merighi, A.; Salio, C.; Ferrini, F.; and Lossi, L. (2011) Neuromodulatory function of neuropeptides in the normal CNS J. Chem. Neuroanat. 42, 276-287
28. Fuxe, K.; Dahlstrom, A. B.; Jonsson, G.; Marcellino, D.; Guescini, M.; Dam, M.; Manger, P.; and Agnati, L. (2010) The discovery of central monoamine neurons gave volume transmission to the wired brain Prog. Neurobiol. 90, 82-100
29. Salio, C.; Lossi, L.; Ferrini, F.; and Merighi, A. (2006) Neuropeptides as synaptic transmitters Cell Tissue Res. 326, 583-598
30. Wollemann, M. and Benyhe, S. (2004) Non-opioid actions of opioid peptides Life Sci. 75, 257-270
31. Reed, B.; Zhang, Y.; Chait, B. T.; and Kreek, M. J. (2003) Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry J. Neurochem. 86, 815-823
32. Tang, Q.; Gandhoke, R.; Burritt, A.; Hruby, V. J.; Porreca, F.; and Lai, J. (1999) High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors J. Pharmacol. Exp. Ther. 291, 760-765
33. Zhang, L.; Peoples, R. W.; Oz, M.; Harvey-White, J.; Weight, F. F.; and Brauneis, U. (1997) Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations J. Neurophysiol. 78, 582-590
34. Quillan, J. M. and Sadee, W. (1997) Dynorphin peptides: Antagonists of melanocortin receptors Pharm. Res. 14, 713-719
35. Shippenberg, T. S.; Funada, M.; and Schutz, C. G. (2000) Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat Psychopharmacology 151, 351-358
36. Schwarzer, C. (2009) 30 years of dynorphins - new insights on their functions in neuropsychiatric diseases Pharmacol. Ther. 123, 353-370
37. Minami, M. and Satoh, M. (1995) Molecular biology of the opioid receptors: structures, functions and distributions Neurosci. Res. 23, 121-145
38. Asvadi, N. H.; Morgan, M.; Hewavitharana, A. K.; Shaw, P. N.; and Cabot, P. J. (2014) Biotransformation of beta-endorphin and possible therapeutic implications Front. Pharmacol. 5, 18
39. Nylander, I.; Tan-No, K.; Winter, A.; and Silberring, J. (1995) Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography Life Sci. 57, 123-129
40. Klintenberg, R. and Andren, P. E. (2005) Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinsons disease J. Mass Spectrom. 40, 261-270
41. Rozenfeld, R. and Devi, L. A. (2007) Receptor heterodimerization leads to a switch in signaling: beta-Arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers FASEB J. 21, 2455-2465
42. Waldhoer, M.; Fong, J.; Jones, R. M.; Lunzer, M. M.; Sharma, S. K.; Kostenis, E.; Portoghese, P. S.; and Whistler, J. L. (2005) A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers Proc. Natl. Acad. Sci. U.S.A. 102, 9050-9055
43. Mendez, M.; Barbosa-Luna, I. G.; Perez-Luna, J. M.; Cupo, A.; and Oikawa, J. (2010) Effects of acute ethanol administration on methionine-enkephalin expression and release in regions of the rat brain Neuropeptides 44, 413-420
44. Olszewski, P. K.; Alsio, J.; Schioth, H. B.; and Levine, A. S. (2011) Opioids as facilitators of feeding: can any food be rewarding? Physiol. Behav. 104, 105-110
45. Nadal, X.; La Porta, C.; Andreea Bura, S.; and Maldonado, R. (2013) Involvement of the opioid and cannabinoid systems in pain control: New insights from knockout studies Eur. J. Pharmacol. 716, 142-157
46. Pardridge, W. M.; Triguero, D.; and Buciak, J. L. (1990) Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain Endocrinology 126, 977-984
47. Bickel, U.; Yoshikawa, T.; and Pardridge, W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier Adv. Drug Delivery Rev. 46, 247-279
48. Alumets, J.; Hakanson, R.; Sundler, F.; and Chang, K. J. (1978) Leu-enkephalin-like material in nerves and enterochromaffin cells in the gut. An immunohistochemical study Histochemistry 56, 187-196
49. Perlikowska, R. and Janecka, A. (2014) Bioavailability of endomorphins and the blood-brain barrier - a review Med. Chem. 10, 2-17
50. Vogel, C. and Marcotte, E. M. (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses Nat. Rev. Genet. 13, 227-232
51. von Zastrow, M. (2010) Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications Drug Alcohol Depend. 108, 166-171
52. Keith, D. E.; Anton, B.; Murray, S. R.; Zaki, P. A.; Chu, P. C.; Lissin, D. V.; Monteillet-Agius, G.; Stewart, P. L.; Evans, C. J.; and von Zastrow, M. (1998) mu-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain Mol. Pharmacol. 53, 377-384
53. Bian, J. M.; Wu, N.; Su, R. B.; and Li, J. (2012) Opioid receptor trafficking and signaling: What happens after opioid receptor activation? Cell. Mol. Neurobiol. 32, 167-184
54. Noble, F. and Roques, B. P. (2007) Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs Exp. Opin. Ther. Targets 11, 145-159
55. Henriksen, G. and Willoch, F. (2008) Imaging of opioid receptors in the central nervous system Brain 131, 1171-1196
56. Scott, D. J.; Stohler, C. S.; Egnatuk, C. M.; Wang, H.; Koeppe, R. A.; and Zubieta, J. K. (2008) Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses Arch. Gen. Psychiatry 65, 220-231
57. Boecker, H.; Sprenger, T.; Spilker, M. E.; Henriksen, G.; Koppenhoefer, M.; Wagner, K. J.; Valet, M.; Berthele, A.; and Tolle, T. R. (2008) The runners high: Opioidergic mechanisms in the human brain Cereb. Cortex 18, 2523-2531
58. Bencherif, B.; Guarda, A. S.; Colantuoni, C.; Ravert, H. T.; Dannals, R. F.; and Frost, J. J. (2005) Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior J. Nucl. Med. 46, 1349-1351
59. Wey, H. Y.; Catana, C.; Hooker, J. M.; Dougherty, D. D.; Knudsen, G. M.; Wang, D. J.; Chonde, D. B.; Rosen, B. R.; Gollub, R. L.; and Kong, J. (2014) Simultaneous fMRI-PET of the opioidergic pain system in human brain NeuroImage 102P2, 275-282
60. Dannals, R. F. (2013) Positron emission tomography radioligands for the opioid system J. Labelled Compd. Radiopharm. 56, 187-195
61. Febo, M. and Ferris, C. F. (2014) Oxytocin and vasopressin modulation of the neural correlates of motivation and emotion: results from functional MRI studies in awake rats Brain Res. 1580, 8-21
62. Ferris, C. F.; Kulkarni, P.; Sullivan, J. M.; Jr.; Harder, J. A.; Messenger, T. L.; and Febo, M. (2005) Pup suckling is more rewarding than cocaine: Evidence from functional magnetic resonance imaging and three-dimensional computational analysis J. Neurosci. 25, 149-156
63. Kennedy, R. T. (2013) Emerging trends in in vivo neurochemical monitoring by microdialysis Curr. Opin. Chem. Biol. 17, 860-867
64. Nandi, P. and Lunte, S. M. (2009) Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: A review Anal. Chim. Acta 651, 1-14
65. Chefer, V. I.; Thompson, A. C.; Zapata, A.; and Shippenberg, T. S. (2009) Overview of brain microdialysis, in Current Protocols in Neuroscience (Crawley, J.; et al.; Eds.) Chapter 7, Unit 7.1, Wiley, New York.
66. Wotjak, C. T.; Landgraf, R.; and Engelmann, M. (2008) Listening to neuropeptides by microdialysis: echoes and new sounds? Pharmacol.; Biochem.; Behav. 90, 125-134
67. Roy, M. C.; Ikimura, K.; Nishino, H.; and Naito, T. (2010) A high recovery microsampling device based on a microdialysis probe for peptide sampling Anal. Biochem. 399, 305-307
68. Lisi, T. L. and Sluka, K. A. (2006) A new electrochemical HPLC method for analysis of enkephalins and endomorphins J. Neurosci. Methods 150, 74-79
69. Shen, H.; Lada, M. W.; and Kennedy, R. T. (1997) Monitoring of Met-enkephalin in vivo with 5-min temporal resolution using microdialysis sampling and capillary liquid chromatography with electrochemical detection J. Chromatogr. B: Biomed. Sci. Appl. 704, 43-52
70. Li, Q.; Zubieta, J. K.; and Kennedy, R. T. (2009) Practical aspects of in vivo detection of neuropeptides by microdialysis coupled off-line to capillary LC with multistage MS Anal. Chem. 81, 2242-2250
71. Bernay, B.; Gaillard, M. C.; Guryca, V.; Emadali, A.; Kuhn, L.; Bertrand, A.; Detraz, I.; Carcenac, C.; Savasta, M.; Brouillet, E.; Garin, J.; and Elalouf, J. M. (2009) Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics Mol. Cell. Proteomics 8, 946-958
72. Haskins, W. E.; Watson, C. J.; Cellar, N. A.; Powell, D. H.; and Kennedy, R. T. (2004) Discovery and neurochemical screening of peptides in brain extracellular fluid by chemical analysis of in vivo microdialysis samples Anal. Chem. 76, 5523-5533
73. Fricker, L. D. (2010) Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins Mol. BioSyst. 6, 1355-1365
74. Rocha, L. and Maidment, N. T. (2003) Opioid peptide release in the rat hippocampus after kainic acid-induced status epilepticus Hippocampus 13, 472-480
75. Rocha, L. L.; Evans, C. J.; and Maidment, N. T. (1997) Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis J. Neurochem. 68, 616-624
76. Maidment, N. T.; Brumbaugh, D. R.; Rudolph, V. D.; Erdelyi, E.; and Evans, C. J. (1989) Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo Neuroscience 33, 549-557
77. Curtis, A. L.; Bello, N. T.; and Valentino, R. J. (2001) Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination J. Neurosci. 21, RC152
78. Binder, W.; Mousa, S. A.; Sitte, N.; Kaiser, M.; Stein, C.; and Schafer, M. (2004) Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue Eur. J. Neurosci. 20, 92-100
79. Wager, T. D.; Scott, D. J.; and Zubieta, J. K. (2007) Placebo effects on human mu-opioid activity during pain Proc. Natl. Acad. Sci. U.S.A. 104, 11056-11061
80. Chen, W. and Marvizon, J. C. (2009) Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization Neuroscience 161, 157-172
81. Roth-Deri, I.; Zangen, A.; Aleli, M.; Goelman, R. G.; Pelled, G.; Nakash, R.; Gispan-Herman, I.; Green, T.; Shaham, Y.; and Yadid, G. (2003) Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens J. Neurochem. 84, 930-938
82. Tsuchiyama, H. (1975) [Morphology of adrenal cortex hyperplasia - with special reference to nodular hyperplasia] Clin. Endocrinol. (Tokyo) 23, 287-292
83. Olive, M. F.; Koenig, H. N.; Nannini, M. A.; and Hodge, C. W. (2001) Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine J. Neurosci. 21, RC184
84. Nieto, M. M.; Wilson, J.; Cupo, A.; Roques, B. P.; and Noble, F. (2002) Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study J. Neurosci. 22, 1034-1041
85. Olive, M. F. and Maidment, N. T. (1998) Opioid regulation of pallidal enkephalin release: Bimodal effects of locally administered mu and delta opioid agonists in freely moving rats J. Pharmacol. Exp. Ther. 285, 1310-1316
86. You, Z. B.; Herrera-Marschitz, M.; Nylander, I.; Goiny, M.; Kehr, J.; Ungerstedt, U.; and Terenius, L. (1996) Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats Brain Res. 710, 241-248
87. Olive, M. F.; Bertolucci, M.; Evans, C. J.; and Maidment, N. T. (1995) Microdialysis reveals a morphine-induced increase in pallidal opioid peptide release Neuroreport 6, 1093-1096
88. Olive, M. F. and Maidment, N. T. (1998) Repeated heroin administration increases extracellular opioid peptide-like immunoreactivity in the globus pallidus/ventral pallidum of freely moving rats Psychopharmacology 139, 251-254
89. Solinas, M.; Zangen, A.; Thiriet, N.; and Goldberg, S. R. (2004) Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol Eur. J. Neurosci. 19, 3183-3192
90. Valverde, O.; Noble, F.; Beslot, F.; Dauge, V.; Fournie-Zaluski, M. C.; and Roques, B. P. (2001) Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect Eur. J. Neurosci. 13, 1816-1824
91. Lam, M. P. and Gianoulakis, C. (2011) Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala Alcohol 45, 621-630
92. Lam, M. P.; Nurmi, H.; Rouvinen, N.; Kiianmaa, K.; and Gianoulakis, C. (2010) Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats Psychopharmacology 208, 121-130
93. Jarjour, S.; Bai, L.; and Gianoulakis, C. (2009) Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area Alcohol.: Clin. Exp. Res. 33, 1033-1043
94. Marinelli, P. W.; Bai, L.; Quirion, R.; and Gianoulakis, C. (2005) A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration Alcohol.: Clin. Exp. Res. 29, 1821-1828
95. Zangen, A. and Shalev, U. (2003) Nucleus accumbens beta-endorphin levels are not elevated by brain stimulation reward but do increase with extinction Eur. J. Neurosci. 17, 1067-1072
96. DiFeliceantonio, A. G.; Mabrouk, O. S.; Kennedy, R. T.; and Berridge, K. C. (2012) Enkephalin surges in dorsal neostriatum as a signal to eat Curr. Biol. 22, 1918-1924
97. Murphy, N. P. (2010) The nociceptin/orphanin FQ system as a target for treating alcoholism CNS Neurol. Disord.: Drug Targets 9, 87-93
98. Matta, S. G.; Balfour, D. J.; Benowitz, N. L.; Boyd, R. T.; Buccafusco, J. J.; Caggiula, A. R.; Craig, C. R.; Collins, A. C.; Damaj, M. I.; Donny, E. C.; Gardiner, P. S.; Grady, S. R.; Heberlein, U.; Leonard, S. S.; Levin, E. D.; Lukas, R. J.; Markou, A.; Marks, M. J.; McCallum, S. E.; Parameswaran, N.; Perkins, K. A.; Picciotto, M. R.; Quik, M.; Rose, J. E.; Rothenfluh, A.; Schafer, W. R.; Stolerman, I. P.; Tyndale, R. F.; Wehner, J. M.; and Zirger, J. M. (2007) Guidelines on nicotine dose selection for in vivo research Psychopharmacology 190, 269-319
99. Risinger, F. O. and Oakes, R. A. (1995) Nicotine-induced conditioned place preference and conditioned place aversion in mice Pharmacol.; Biochem.; Behav. 51, 457-461
100. Di Chiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U.S.A. 85, 5274-5278
101. Schultz, W.; Dayan, P.; and Montague, P. R. (1997) A neural substrate of prediction and reward Science 275, 1593-1599
102. Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Rev. 18, 247-291
103. Kehr, J. and Yoshitake, T. (2013) Monitoring molecules in neuroscience: historical overview and current advancements Front. Biosci.; Elite Ed. 5, 947-954
104. Vlachou, S. and Markou, A. (2011) Intracranial Self-Stimulation, in Animal Models of Drug Addiction (Olmstead, M. C.; Ed.), pp 3-56, Humana Press, Totowa, NJ.
105. Shippenberg, T. S. (2009) The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders? Neuropsychopharmacology 34, 247
106. Padwal, R. (2009) Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity Curr. Opin. Invest. Drugs 10, 1117-1125
107. Pettinati, H. M.; OBrien, C. P.; Rabinowitz, A. R.; Wortman, S. P.; Oslin, D. W.; Kampman, K. M.; and Dackis, C. A. (2006) The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking J. Clin. Psychopharmacol. 26, 610-625
108. Tzschentke, T. M. (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade Addict. Biol. 12, 227-462
109. Beinfeld, M. C. (2003) What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization Life Sci. 73, 643-654
110. Schultz, W. (2013) Updating dopamine reward signals Curr. Opin. Neurobiol. 23, 229-238
111. Berridge, K. C.; Robinson, T. E.; and Aldridge, J. W. (2009) Dissecting components of reward: "liking, "wanting, and learning Curr. Opin. Pharmacol. 9, 65-73
112. Richard, J. M.; Castro, D. C.; Difeliceantonio, A. G.; Robinson, M. J.; and Berridge, K. C. (2013) Mapping brain circuits of reward and motivation: In the footsteps of Ann Kelley Neurosci. Biobehav. Rev. 37, 1919-1931
113. Wassum, K. M.; Cely, I. C.; Balleine, B. W.; and Maidment, N. T. (2011) Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward J. Neurosci. 31, 1591-1599
114. Berridge, K. C. and Robinson, T. E. (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Rev. 28, 309-369
115. Kelly, M. J.; Loose, M. D.; and Ronnekleiv, O. K. (1990) Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance Neuroendocrinology 52, 268-275
116. Jones, S. and Bonci, A. (2005) Synaptic plasticity and drug addiction Curr. Opin. Pharmacol. 5, 20-25
117. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2, 119-128
118. Dacher, M. and Nugent, F. S. (2011) Opiates and plasticity Neuropharmacology 61, 1088-1096